While left ventricular assist devices (LVADs) are common treatment for patients with heart failure, a sizeable portion of LVAD recipients demonstrate clinically significant postoperative right ventricular failure and potentially require a biventricular assist device (BiVAD). This chapter presents a summary of BiVAD requirements and then reviews several devices that have been used clinically. The majority of these devices are first-generation, pulsatile, paracorporeal systems that are large and unsuitable for long-term support with complications such as device failure, thrombus formation, infection, and severely reduced patient mobility. With the development of rotary blood pumps, more reliable BiVAD options are entering the clinical arena. ...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
The use of rotary left ventricular assist devices (LVADs) has extended to destination and recovery t...
While left ventricular assist devices (LVADs) are common treatment for patients with heart failure, ...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
University of Technology Sydney. Faculty of Health.Patients with severe biventricular failure are of...
© 2016 by the ASAIO. Right ventricular failure after left ventricular assist device (LVAD) implantat...
Right ventricular failure after left ventricular assist device (LVAD) implantation is associated wit...
Right ventricular failure following left ventricular assist devices implantation is a serious compli...
Left ventricular assist devices (LVADs) have been developed to support end-stage heart failure patie...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
The BiVACOR is a novel rotary Biventricular Assist Device (BiVAD) undergoing development to treat gl...
Left ventricular assist systems with portable drive units are increasingly used in the clinical sett...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Background There is limited information on outcomes using the HeartWare ventricular assist device (H...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
The use of rotary left ventricular assist devices (LVADs) has extended to destination and recovery t...
While left ventricular assist devices (LVADs) are common treatment for patients with heart failure, ...
The optimal treatment option for end stage heart failure is transplantation; however, the shortage o...
University of Technology Sydney. Faculty of Health.Patients with severe biventricular failure are of...
© 2016 by the ASAIO. Right ventricular failure after left ventricular assist device (LVAD) implantat...
Right ventricular failure after left ventricular assist device (LVAD) implantation is associated wit...
Right ventricular failure following left ventricular assist devices implantation is a serious compli...
Left ventricular assist devices (LVADs) have been developed to support end-stage heart failure patie...
In patients with refractory end-stage heart failure, cardiac transplantation remains the only establ...
The BiVACOR is a novel rotary Biventricular Assist Device (BiVAD) undergoing development to treat gl...
Left ventricular assist systems with portable drive units are increasingly used in the clinical sett...
Recent outstanding clinical advances with new mechanical circulatory systems have led to additional ...
Background There is limited information on outcomes using the HeartWare ventricular assist device (H...
Recent outstanding clinical advances with new mechanical circulatory systems (MCS) have led to addit...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
The use of rotary left ventricular assist devices (LVADs) has extended to destination and recovery t...